共 50 条
- [31] Knowledge-based potentials in drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U36 - U36
- [32] Shape-based denovo drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U498 - U498
- [33] Shape signatures and receptor based drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U529
- [34] RAPID: Randomized pharmacophore identification for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 95 - COMP
- [35] Free energy calculations in rational drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U896 - U896
- [36] Catalytic chelators: Mechanism and implications for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U212 - U212
- [37] Protein family clustering as an aid to drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U425 - U425
- [38] New reagents, reactions, and peptidomimetics for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U75 - U76
- [39] Discovery of risedronate: An interdisciplinary approach in drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U34 - U34
- [40] Catalytic chelators: Mechanism and implications for drug design. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U833 - U833